Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2009 Dec 4

PMID 19956630

Citations 12

Authors

Yanyan Hong

Hongzhi Li

Jingjing Ye

Yasuhiro Miki

Yate-Ching Yuan

Hironobu Sasano

Dean B Evans

Shiuan Chen

Affiliations

Soon will be listed here.

Abstract

Immunohistochemistry is one of the most suitable methods for the detection of intratumoral aromatase in order to identify patients who may respond to aromatase inhibitor therapy in hormone-dependent breast cancer. Previous studies showed statistically significant correlation between results of immnuohistochemistry and biochemical analysis in carcinoma components stained by aromatase monoclonal antibody 677. In this study, determination of the antigenic peptides recognized by aromatase antibodies through epitope mapping, combined with the new knowledge on aromatase-reductase interaction, provide insights for understanding various immunostaining patterns using different aromatase antibodies. Our studies on aromatase-reductase interaction also provided critical information on how aromatase and reductase interact with each other on the endoplasmic reticulum membrane, and identified key residues, including K108 of aromatase, that are involved in the interaction with reductase. Through epitope mapping and taking into consideration the interference with aromatase immunohistochemical staining by NADPH-cytochrome P450 reductase, we demonstrated that monoclonal antibody 677 is a suitable antibody for an assessment of intratumoral aromatase activity in breast cancer patients for making clinical management decisions. These results also provide valuable information to identify new aromatase antibodies for immunohistochemical diagnosis of hormone-dependent breast cancer in future.

Citing Articles

Influence of cholesterol on kinetic parameters for human aromatase (P450 19A1) in phospholipid nanodiscs.

Sumangala N, Im S, Valentin-Goyco J, Auchus R J Inorg Biochem. 2023; 247:112340.

PMID: 37544101 PMC: 11260420. DOI: 10.1016/j.jinorgbio.2023.112340.

Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases.

de Andres P, Caceres S, Illera J, Crespo B, Silvan G, Queiroga F Vet Sci. 2022; 9(8).

PMID: 36006309 PMC: 9414677. DOI: 10.3390/vetsci9080395.

Influence of CYP19A1 gene expression levels in women with breast cancer: a systematic review of the literature.

Barros-Oliveira M, Costa-Silva D, Dos Santos A, Pereira R, Soares-Junior J, Silva B Clinics (Sao Paulo). 2021; 76:e2846.

PMID: 34133482 PMC: 8183338. DOI: 10.6061/clinics/2021/e2846.

Molecular and Structural Evolution of Cytochrome P450 Aromatase.

Di Nardo G, Zhang C, Marcelli A, Gilardi G Int J Mol Sci. 2021; 22(2).

PMID: 33435208 PMC: 7827799. DOI: 10.3390/ijms22020631.

Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition.

Molehin D, Castro-Piedras I, Sharma M, Sennoune S, Arena D, Manna P Mol Cancer Res. 2018; 16(10):1530-1542.

PMID: 29921733 PMC: 7881835. DOI: 10.1158/1541-7786.MCR-18-0047.

References

Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs D . Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology. 1996; 137(7):3061-8. DOI: 10.1210/endo.137.7.8770932. View

Sasano H, Anderson T, Silverberg S, Santen R, Conway M, Edwards D . The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol. 2005; 95(1-5):35-9. DOI: 10.1016/j.jsbmb.2005.04.027. View

Bernhardt R, Pommerening K, Ruckpaul K . Modification of carboxyl groups on NADPH-cytochrome P-450 reductase involved in binding of cytochromes c and P-450 LM2. Biochem Int. 1987; 14(5):823-32. View

Nelson D, Strobel H . On the membrane topology of vertebrate cytochrome P-450 proteins. J Biol Chem. 1988; 263(13):6038-50. View

Shimizu T, Tateishi T, Hatano M, Fujii-Kuriyama Y . Probing the role of lysines and arginines in the catalytic function of cytochrome P450d by site-directed mutagenesis. Interaction with NADPH-cytochrome P450 reductase. J Biol Chem. 1991; 266(6):3372-5. View

Nadler S, Strobel H . Role of electrostatic interactions in the reaction of NADPH-cytochrome P-450 reductase with cytochromes P-450. Arch Biochem Biophys. 1988; 261(2):418-29. DOI: 10.1016/0003-9861(88)90358-x. View

Ghosh D, Griswold J, Erman M, Pangborn W . Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature. 2009; 457(7226):219-23. PMC: 2820300. DOI: 10.1038/nature07614. View

Hong Y, Li H, Yuan Y, Chen S . Molecular characterization of aromatase. Ann N Y Acad Sci. 2009; 1155:112-20. PMC: 3253311. DOI: 10.1111/j.1749-6632.2009.03703.x. View

Nadler S, Strobel H . Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450. Arch Biochem Biophys. 1991; 290(2):277-84. DOI: 10.1016/0003-9861(91)90542-q. View

10.

Hong Y, Yu B, Sherman M, Yuan Y, Zhou D, Chen S . Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase. Mol Endocrinol. 2006; 21(2):401-14. DOI: 10.1210/me.2006-0281. View

11.

Shen A, Porter T, Wilson T, Kasper C . Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. J Biol Chem. 1989; 264(13):7584-9. View

12.

Miller W, ONeill J . The importance of local synthesis of estrogen within the breast. Steroids. 1987; 50(4-6):537-48. DOI: 10.1016/0039-128x(87)90037-7. View

13.

Shenton K, Dowsett M, Lu Q, Brodie A, Sasano H, Sacks N . Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas. Breast Cancer Res Treat. 1998; 49 Suppl 1:S101-7; discussion S109-19. DOI: 10.1023/a:1006033813899. View

14.

Bulun S, Price T, Aitken J, Mahendroo M, Simpson E . A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab. 1993; 77(6):1622-8. DOI: 10.1210/jcem.77.6.8117355. View

15.

Sasano H, Nagura H, Harada N, Goukon Y, Kimura M . Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol. 1994; 25(5):530-5. DOI: 10.1016/0046-8177(94)90127-9. View

16.

Zhou D, Pompon D, Chen S . Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. Cancer Res. 1990; 50(21):6949-54. View

17.

Strobel H, Nadler S, Nelson D . Cytochrome P-450: cytochrome P-450 reductase interactions. Drug Metab Rev. 1989; 20(2-4):519-33. DOI: 10.3109/03602538909103558. View

18.

James V, McNeill J, Lai L, Newton C, Ghilchik M, Reed M . Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids. 1987; 50(1-3):269-79. DOI: 10.1016/0039-128x(83)90077-6. View

19.

Nisimoto Y . Localization of cytochrome c-binding domain on NADPH-cytochrome P-450 reductase. J Biol Chem. 1986; 261(30):14232-9. View

20.

Stayton P, Sligar S . The cytochrome P-450cam binding surface as defined by site-directed mutagenesis and electrostatic modeling. Biochemistry. 1990; 29(32):7381-6. DOI: 10.1021/bi00484a005. View